JP2011530514A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011530514A5 JP2011530514A5 JP2011522119A JP2011522119A JP2011530514A5 JP 2011530514 A5 JP2011530514 A5 JP 2011530514A5 JP 2011522119 A JP2011522119 A JP 2011522119A JP 2011522119 A JP2011522119 A JP 2011522119A JP 2011530514 A5 JP2011530514 A5 JP 2011530514A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- nos
- acid sequences
- sequences shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XJOTXKZIRSHZQV-RXHOOSIZSA-N (3S)-3-amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S,3S)-1-[[(1R,6R,12R,17R,20S,23S,26R,31R,34R,39R,42S,45S,48S,51S,59S)-51-(4-aminobutyl)-31-[[(2S)-6-amino-1-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-1-oxohexan-2-yl]carbamoyl]-20-benzyl-23-[(2S)-butan-2-yl]-45-(3-carbamimidamidopropyl)-48-(hydroxymethyl)-42-(1H-imidazol-4-ylmethyl)-59-(2-methylsulfanylethyl)-7,10,19,22,25,33,40,43,46,49,52,54,57,60,63,64-hexadecaoxo-3,4,14,15,28,29,36,37-octathia-8,11,18,21,24,32,41,44,47,50,53,55,58,61,62,65-hexadecazatetracyclo[32.19.8.26,17.212,39]pentahexacontan-26-yl]amino]-3-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)[C@@H](C)O)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@@H](NC1=O)[C@@H](C)CC)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc1cnc[nH]1)NC3=O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N2)C(=O)NCC(=O)N4)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XJOTXKZIRSHZQV-RXHOOSIZSA-N 0.000 claims description 13
- 102400001151 Hepcidin-25 Human genes 0.000 claims description 12
- 101800003310 Hepcidin-25 Proteins 0.000 claims description 12
- 229920001184 polypeptide Polymers 0.000 claims description 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- 210000002966 serum Anatomy 0.000 claims description 4
- 102000009052 human hepcidin 25 Human genes 0.000 claims description 3
- 108700022871 human hepcidin 25 Proteins 0.000 claims description 3
- 238000003018 immunoassay Methods 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 150000001413 amino acids Chemical group 0.000 claims 25
- 238000000034 method Methods 0.000 claims 8
- 239000007787 solid Substances 0.000 claims 4
- 239000013060 biological fluid Substances 0.000 claims 3
- 210000001519 tissue Anatomy 0.000 claims 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
- 208000007502 anemia Diseases 0.000 claims 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims 2
- 206010003445 Ascites Diseases 0.000 claims 1
- 238000002965 ELISA Methods 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102000001554 Hemoglobins Human genes 0.000 claims 1
- 108010054147 Hemoglobins Proteins 0.000 claims 1
- 210000004381 amniotic fluid Anatomy 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 238000004820 blood count Methods 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 210000002726 cyst fluid Anatomy 0.000 claims 1
- 210000003743 erythrocyte Anatomy 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 238000005534 hematocrit Methods 0.000 claims 1
- 210000004251 human milk Anatomy 0.000 claims 1
- 235000020256 human milk Nutrition 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- 210000002751 lymph Anatomy 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 238000001556 precipitation Methods 0.000 claims 1
- 238000003127 radioimmunoassay Methods 0.000 claims 1
- 210000001995 reticulocyte Anatomy 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 238000003118 sandwich ELISA Methods 0.000 claims 1
- 210000004243 sweat Anatomy 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
- 102000018511 hepcidin Human genes 0.000 description 2
- 108060003558 hepcidin Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229940066919 hepcidin Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8655708P | 2008-08-06 | 2008-08-06 | |
| US61/086,557 | 2008-08-06 | ||
| PCT/US2009/052044 WO2010017070A1 (en) | 2008-08-06 | 2009-07-29 | Anti-hepcidin-25 selective antibodies and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011530514A JP2011530514A (ja) | 2011-12-22 |
| JP2011530514A5 true JP2011530514A5 (enExample) | 2013-06-06 |
| JP5730200B2 JP5730200B2 (ja) | 2015-06-03 |
Family
ID=41165490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011522119A Expired - Fee Related JP5730200B2 (ja) | 2008-08-06 | 2009-07-29 | 抗ヘプシジン−25選択的抗体およびその使用 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8609817B2 (enExample) |
| EP (1) | EP2328931B1 (enExample) |
| JP (1) | JP5730200B2 (enExample) |
| KR (1) | KR101462307B1 (enExample) |
| CN (1) | CN102112489B (enExample) |
| AU (1) | AU2009279865B2 (enExample) |
| BR (1) | BRPI0916624A2 (enExample) |
| CA (1) | CA2733497C (enExample) |
| DK (1) | DK2328931T3 (enExample) |
| EA (1) | EA201170312A1 (enExample) |
| ES (1) | ES2432018T3 (enExample) |
| IL (1) | IL210643A (enExample) |
| MX (1) | MX2011001363A (enExample) |
| NZ (1) | NZ590863A (enExample) |
| PL (1) | PL2328931T3 (enExample) |
| PT (1) | PT2328931E (enExample) |
| UA (1) | UA103032C2 (enExample) |
| WO (1) | WO2010017070A1 (enExample) |
| ZA (1) | ZA201100261B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2336176B1 (en) * | 2003-04-01 | 2015-05-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antibodies directed against hepatitis c virus e1e2 complex, and their epitopes |
| AR069062A1 (es) * | 2007-11-02 | 2009-12-23 | Lilly Co Eli | Anticuerpo anti-hepcidina |
| CA2808392C (en) | 2010-08-16 | 2020-03-10 | Pieris Ag | Binding proteins for hepcidin |
| US9610356B2 (en) | 2011-12-12 | 2017-04-04 | Pieris Pharmaceutical GmbH | Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation |
| US10316103B1 (en) | 2012-03-30 | 2019-06-11 | Biocare Medical, Llc | Systems and methods for anti-Uroplakin III antibodies |
| US20140120560A1 (en) * | 2012-10-26 | 2014-05-01 | Claresa Levetan | Generation of new pancreatic beta cells |
| US10429390B2 (en) | 2012-12-18 | 2019-10-01 | Biocare Medical, Llc | Antibody cocktail systems and methods for classification of histologic subtypes in lung cancer |
| DK2968503T3 (en) * | 2013-03-15 | 2018-12-03 | Intrinsic Lifesciences Llc | ANTI-HEPCIDIN ANTIBODIES AND APPLICATIONS THEREOF |
| DK3052522T3 (da) * | 2013-10-03 | 2020-02-24 | Biocare Medical Llc | Anti-sox 10 antistofsystemer og -fremgangsmåder |
| WO2016027469A1 (ja) * | 2014-08-21 | 2016-02-25 | 国立大学法人旭川医科大学 | ヘプシジンのスプライシングバリアント並びに該バリアントを指標とした癌の診断方法 |
| EP3197915A4 (en) * | 2014-09-22 | 2018-12-19 | Intrinsic Lifesciences LLC | Humanized anti-hepcidin antibodies and uses thereof |
| EP3268027B1 (en) | 2015-03-13 | 2022-11-02 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Hepcidin antagonists for use in the treatment of inflammation |
| WO2018063963A1 (en) * | 2016-09-28 | 2018-04-05 | Board Of Regents, The University Of Texas System | Antibody and protein therapeutic formulations and uses thereof |
| EA201991204A1 (ru) | 2016-12-22 | 2019-12-30 | Университа Дельи Студи Манья Греча Катандзаро | Моноклональное антитело против уникального сиалогликозилированного опухолеассоциированного эпитопа cd43 |
| WO2018234538A1 (en) | 2017-06-23 | 2018-12-27 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Hepcidin antagonist or agonist for use in the treatment of dysregulation of mo and/or mn metabolism |
| CN109948371B (zh) * | 2019-03-07 | 2021-06-25 | 深圳市智税链科技有限公司 | 为区块链节点发放身份证书的方法及相关装置 |
| KR20220088699A (ko) | 2019-09-27 | 2022-06-28 | 디스크 메디슨, 인크. | 골수섬유증 및 관련 상태의 치료 방법 |
| KR20230012539A (ko) | 2020-05-13 | 2023-01-26 | 디스크 메디슨, 인크. | 골수섬유증을 치료하기 위한 항-헤모주벨린 (hjv) 항체 |
| WO2022098812A1 (en) | 2020-11-04 | 2022-05-12 | Keros Therapeutics, Inc. | Methods of treating iron overload |
| JPWO2022154121A1 (enExample) * | 2021-01-18 | 2022-07-21 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004522402A (ja) | 1999-06-02 | 2004-07-29 | ジェネンテック・インコーポレーテッド | 同一のものをコードする分泌及び膜貫通ポリペプチドと核酸 |
| US6262247B1 (en) | 1999-08-30 | 2001-07-17 | Incyte Genomics, Inc. | Polycyclic aromatic hydrocarbon induced molecules |
| CA2448382C (en) * | 2001-05-25 | 2013-02-19 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Use of hepcidin as a regulator of iron homeostasis |
| CN1173737C (zh) | 2002-10-21 | 2004-11-03 | 钱忠明 | Hepcidin(海魄喜定)在制药中的应用 |
| US8017737B2 (en) * | 2002-11-19 | 2011-09-13 | Hasan Kulaksiz | Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids; monoclonal antibodies specific to human hepcidin and associated uses therefor |
| EP1578254B1 (en) | 2002-11-19 | 2013-03-06 | DRG International, Inc. | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| US7411048B2 (en) * | 2002-11-19 | 2008-08-12 | Drg International, Inc. | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids |
| US20050033029A1 (en) | 2003-06-30 | 2005-02-10 | Jin Lu | Engineered anti-target immunoglobulin derived proteins, compositions, methods and uses |
| EP1673465A4 (en) | 2003-09-29 | 2008-04-30 | Biosite Inc | PROCESS AND COMPOSITIONS FOR SEPSIS DIAGNOSIS |
| AU2003271174A1 (en) * | 2003-10-10 | 2005-04-27 | Chugai Seiyaku Kabushiki Kaisha | Double specific antibodies substituting for functional protein |
| US7723063B2 (en) * | 2004-04-28 | 2010-05-25 | Intrinsic Lifesciences | Methods for measuring levels of bioactive human hepcidin |
| NZ560976A (en) * | 2005-03-11 | 2011-06-30 | Univ Johns Hopkins | Biomarkers for ovarian cancer and endometrial cancer: hepcidin |
| PE20090722A1 (es) | 2007-02-02 | 2009-07-13 | Amgen Inc | Hepcidina, antagonistas de la hepcidina y metodos de uso |
| GR1006896B (el) | 2007-08-24 | 2010-07-20 | Ελληνικο Ινστιτουτο Παστερ, | Μεθοδος παραγωγης μιας πεπτιδικης ορμονης |
| ATE553778T1 (de) * | 2007-10-02 | 2012-05-15 | Inst Nat Sante Rech Med | Für humanes hepcidin spezifische antikörper |
| AR069062A1 (es) * | 2007-11-02 | 2009-12-23 | Lilly Co Eli | Anticuerpo anti-hepcidina |
| EP2816059A1 (en) | 2008-05-01 | 2014-12-24 | Amgen, Inc | Anti-hepcidin antibodies and methods of use |
-
2009
- 2009-07-29 ES ES09790908T patent/ES2432018T3/es active Active
- 2009-07-29 DK DK09790908.9T patent/DK2328931T3/da active
- 2009-07-29 MX MX2011001363A patent/MX2011001363A/es active IP Right Grant
- 2009-07-29 BR BRPI0916624A patent/BRPI0916624A2/pt not_active IP Right Cessation
- 2009-07-29 KR KR1020117002748A patent/KR101462307B1/ko not_active Expired - Fee Related
- 2009-07-29 CA CA2733497A patent/CA2733497C/en active Active
- 2009-07-29 NZ NZ590863A patent/NZ590863A/xx not_active IP Right Cessation
- 2009-07-29 PL PL09790908T patent/PL2328931T3/pl unknown
- 2009-07-29 JP JP2011522119A patent/JP5730200B2/ja not_active Expired - Fee Related
- 2009-07-29 EA EA201170312A patent/EA201170312A1/ru unknown
- 2009-07-29 UA UAA201101111A patent/UA103032C2/uk unknown
- 2009-07-29 US US13/055,201 patent/US8609817B2/en not_active Expired - Fee Related
- 2009-07-29 CN CN200980129864.0A patent/CN102112489B/zh not_active Expired - Fee Related
- 2009-07-29 EP EP09790908.9A patent/EP2328931B1/en active Active
- 2009-07-29 WO PCT/US2009/052044 patent/WO2010017070A1/en not_active Ceased
- 2009-07-29 PT PT97909089T patent/PT2328931E/pt unknown
- 2009-07-29 AU AU2009279865A patent/AU2009279865B2/en not_active Ceased
-
2011
- 2011-01-10 ZA ZA2011/00261A patent/ZA201100261B/en unknown
- 2011-01-13 IL IL210643A patent/IL210643A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011530514A5 (enExample) | ||
| CA2733497C (en) | Anti-hepcidin-25 selective antibodies and uses thereof | |
| KR101669918B1 (ko) | 사람 체액 중의 시스타틴 c의 측정방법 | |
| RU2010117018A (ru) | Антитела к gdf8 и их применения | |
| RU2014146707A (ru) | Антитела против тофацитиниба и их применение для лекарственного мониторинга | |
| JP6129956B2 (ja) | 抗c−Met抗体 | |
| JPWO2007114337A1 (ja) | 免疫凝集反応試薬キット及び抗原の測定方法 | |
| JP6873995B2 (ja) | ヘプシジンの検出用キット | |
| CN117624367B (zh) | 抗人cd141蛋白的兔单克隆抗体及其应用 | |
| CN104142406B (zh) | 一种稳定的肌钙蛋白i检测试剂盒 | |
| WO2023013764A1 (ja) | 非アルコール性脂肪性肝炎における線維化進行度および/または前記肝疾患の活動性を推定する方法 | |
| WO2017132062A1 (en) | Cgrp antibodies and uses thereof | |
| CN120192412B (zh) | 抗T3抗体mAb32或抗原结合片段、制备方法和应用 | |
| CN120040588B (zh) | 抗T3抗体mAb68或抗原结合片段、制备方法和应用 | |
| KR20210073785A (ko) | 호산구 유래 신경독과 특이적으로 결합하는 단일클론항체 및 이의 용도 | |
| JP7207517B2 (ja) | App669-711の測定方法、及び測定用キット | |
| JP7715637B2 (ja) | 免疫反応を利用したアナライトの測定方法及び測定試薬 | |
| RU2010149317A (ru) | Способ количественного определения специфических иммуноглобулинов g к низкомолекулярным соединениям в сыворотке крови | |
| CN102597772B (zh) | 5.9kDa肽的免疫学测定方法 | |
| JP4505800B2 (ja) | 抗腎タイプivモノクロ−ナル抗体 | |
| RU2023100156A (ru) | Диагностические анализы и наборы для детекции фолатного рецептора 1 | |
| JP2005298395A (ja) | 抗重金属モノクローナル抗体およびその使用方法 | |
| HK1156326B (en) | Anti-hepcidin-25 selective antibodies and uses thereof | |
| WO2014073653A1 (ja) | 腎炎の病変部位の検査方法およびそのための試薬 |